The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVI Global Trust Regulatory News (AGT)

Share Price Information for AVI Global Trust (AGT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 244.00
Bid: 243.50
Ask: 244.00
Change: 1.50 (0.62%)
Spread: 0.50 (0.205%)
Open: 243.00
High: 245.00
Low: 241.50
Prev. Close: 242.50
AGT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Factsheet

12 Sep 2023 17:20

RNS Number : 2169M
AVI Global Trust PLC
12 September 2023
 

 

AVI GLOBAL TRUST PLC

 

Monthly Update

 

AVI Global Trust plc (the "Company") presents its Update, reporting performance figures for the month ended 31 August 2023.

 

This Monthly Newsletter is available on the Company's website at:

https://www.assetvalueinvestors.com/content/uploads/2023/09/AGT-AUGUST-2023.pdf

 

Performance Total Return

 

This investment management report relates to performance figures to 31 August 2023.

 

Total Return (£)

Month

Calendar Yr

to date

1Y

3Y

5Y

10Y

AGT NAV

0.7%

7.3%

6.3%

43.7%

46.0%

143.4%

MSCI ACWI Ex US

-3.0%

3.3%

2.7%

18.8%

20.8%

87.4%

MSCI ACWI

-1.3%

9.0%

4.6%

30.3%

47.0%

177.5%

 

 

Manager's Comment

 

AVI Global Trust (AGT)'s NAV increased by +0.7% in August.

 

KKR (+6%), Apollo (+7%) and Godrej Industries (+12%) were the most significant contributors. After being written up last month, the newsletter curse struck with unusual venom as IAC was the most significant detractor with a share price decline of -21%. We bought a bit more. Christian Dior (-5%) and D'Ieteren (-5%) also detracted.

 

Pantheon International

 

Pantheon International (PIN) announced a revised capital allocation policy at the beginning of the month, the significance of which should be far-reaching across the listed private equity (LPE) sector.

 

For readers unfamiliar with the company, PIN is one of the oldest listed private equity vehicles and has built up a strong NAV performance record over several decades. The discount on the company's shares began to widen dramatically in early-2022 amidst the broad market sell-off, with the shares at their nadir trading at less than half of NAV. We hold a ~3.5% stake in PIN acquired over 2022 and 2023 at an average discount of 45%. For context, current discounts on buy-out funds in private secondary market trades are reportedly averaging 10-15%.

 

As a matter of arithmetic, returns from share repurchases (i.e., NAV per share accretion) compound with returns from the existing portfolio. For companies trading at the extreme discount levels of PIN and its peers to favour new investments over buybacks relies on either implausibly heroic return assumptions on these new investments or a very pessimistic outlook for the existing portfolio.

 

We were therefore delighted to see PIN announce a large share buyback programme of up to £200m to be completed by the end of May-24. At the prevailing share price and discount on the day prior to the announcement, this equates to 15% of shares outstanding and would generate an uplift to NAV per share in excess of +7%. This translates to an ROI on these repurchases of almost +90%. Furthermore, the Board also disclosed their intent to allocate a proportion of net positive cashflow to share repurchases from the next financial year onwards, the quantum of which will be determined by the discount level.

 

The Board's framing of share buybacks as an investment decision gave us particular cheer. Far too much hot air is expended debating the impact of repurchases on discounts when the pertinent question is instead one of capital allocation, i.e., whether buybacks or new investments will offer superior risk-adjusted returns. At the discount levels on which the listed private equity sector is trading, it is essentially inarguable that the former - which should be looked at as an investment in one's existing portfolio at a price well below NAV - will be the answer.

 

We applaud PIN's Chairman John Singer for engaging in what proved to be an extensive and genuine shareholder consultation exercise, and for having the fortitude to steer these changes through when it may have been easier to hide behind the relative lack of action from many of the company's peers. The Chairman's Statement from PIN's annual results should be required reading for all investment trust directors.

 

Notwithstanding that capital calls tend to slow down at the same time as distributions in times of economic uncertainty, the current market backdrop must of course mean that companies holding illiquid assets ensure they can meet their existing commitments. The extent to which listed private equity companies can match PIN's approach will vary depending on their levels of leverage, outstanding commitments, cash-flow projections, and the exact structure through which they hold their investments. But balance sheets in general are in far better shape than they were during the 2008-09 financial crisis, meaning that the current wide discounts present an extraordinary opportunity to create material value for shareholders through discounted repurchases.

 

PIN has net cash and a large undrawn credit facility. This provides the company with more than sufficient headroom to embark on the £200m share repurchase programme. But PIN also has a relatively low level of commitments, which is in substantial part due to its shift over the last decade towards making direct investments (co-investments and single-asset secondaries) which now form just over half of its portfolio. This ensures far greater flexibility when making capital allocation decisions around buybacks. Boards should, in our view, be mindful of the risk of missing high-return opportunities to acquire their own shares at significant discounts over a cycle and thus should make efforts to structure investments accordingly. For direct LPE funds investing in single managers, that may mean negotiating opt-outs for a portion of commitments; for fund-of-funds, being mindful of the additional flexibility afforded by co-investments as opposed to primary commitments (we note that this has, in fairness, been a growing trend for the latter group albeit not necessarily for this specific reason).

 

More broadly, many of the alternative asset funds outside of the LPE sector had grown used to regularly raising equity to fund new investments. With discounts where they are today (for example, the infrastructure fund peer group currently trades on an average 20% discount with many funds at considerably wider levels), the burden of proof now lies with Boards when it comes to justifying new investments over share repurchases. In that respect, Pantheon have thrown down the gauntlet.

 

PIN's share price has increased by +9% since the 3-Aug-23 announcement, which still leaves the shares on a 38% discount to NAV (or a 42% implied discount on the unlisted portfolio). We see considerable scope for further upside given the presence of a new ongoing buyer in the market in the form of the company itself; the buyback demonstrating confidence in the NAV; the substantial degree of NAV accretion now baked into future returns; the high-quality portfolio still demonstrating robust earnings growth and sizable uplifts over carrying values upon exits; and some recent signs of a thawing of transaction activity.

 

Godrej Industries

 

Shares in Godrej Industries rose +12% in August having hit their widest ever discount level of 69% at the end of July. Although the discount had already started to move in, mid-month the shares received a further boost from incorrect media reports linking Godrej Industries to a successful space mission (with the Godrej family involvement coming through a different unlisted holding company).

 

This rather odd turn of events serves as an apt prompt to provide an update on what has been a relatively unsuccessful investment for AGT - delivering an ROI of just +13% in Rupees and +0.5% in Sterling since 2019 (a meagre IRR of +3.5% / +0.1%).

 

As way of reminder Godrej Industries owns listed stakes in Godrej Consumer Products (49% of NAV), Godrej Properties (44%) and Godrej Agrovet (12%), as well an unlisted Chemicals business (8%) and a nascent finance business (3%). Together the listed stakes account for >200% of Godrej Industries enterprise value.

 

Our initial thesis was predicated on the attractive quality of the underlying assets, most notably Godrej Consumer, and the prospects for long-term NAV growth. As well as this we thought the ~45% discount at which we started accumulating shares in 2019 to be appealing, with it having widened following the 2017 IPO of Godrej Agrovet and liked the alignment with a family with a track record of significant value creation and strong corporate governance. We have been both right and wrong.

 

On the NAV side of the equation performance has been satisfactory. From the date of our first purchase in February 2019 the NAV is up +68% - for a CAGR of +12%. Whilst this has slightly lagged the MSCI India (+74%) it compares favourably to the MSCI AC World (+58% in INR) and provides a good bedrock for returns.

 

It is however the discount which has been the problem - moving from 45% to as wide as 69% and to 64% currently. Such moves are painful and frustrating. That said, we'd much rather lose money from discount widening than declines in NAV, viewing it as a temporary setback, rather than a permanent impairment of value.

 

Godrej Industries has a history of incubating and building businesses, before listing them, with Godrej Agrovet's listing in 2017 having been the most recent. It is likely that Godrej Capital will follow a similar route, and we view this as a medium-term catalyst for improving interest in Godrej Industries shares and narrowing the discount. Arithmetically, prospective discount returns from such wide levels are significant, with a 50% discount resulting in a +37% return. As such, combined with the attractive nature of the underlying NAV, we remain optimistic and patient.

 

Contributors / Detractors (in GBP)

 

Largest Contributors

1- month contribution

bps

% Weight

KKR

48

6.8

Apollo Global Mgmt.

45

5.5

Godrej Industries

37

3.1

News Corp

33

3.7

Pantheon International

27

5.1

 

Largest Detractors

1- month contribution

bps

% Weight

IAC

-73

3.6

Christian Dior

-23

2.0

D'Ieteren

-20

3.8

Digital Garage

-19

1.7

Long Brookfield Corp/ Short Listed Underlyings

-15

5.4

 

 

Link Company Matters Limited

Corporate Secretary

 

12 September 2023

 

LEI: 213800QUODCLWWRVI968

 

The content of the Company's web-pages and the content of any website or pages which may be accessed through hyperlinks on the Company's web-pages, other than the content of the Newsletter referred to above, is neither incorporated into nor forms part of the above announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCGPUMGBUPWGQP
Date   Source Headline
9th May 20245:55 pmRNSTransaction in Own Shares
9th May 202412:46 pmRNSNet Asset Value(s)
8th May 20241:27 pmRNSNet Asset Value(s)
7th May 20241:18 pmRNSNet Asset Value(s)
3rd May 20242:08 pmRNSNet Asset Value(s)
2nd May 20245:43 pmRNSTransaction in Own Shares
2nd May 20241:55 pmRNSNet Asset Value(s)
1st May 20241:39 pmRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 202412:30 pmRNSNet Asset Value(s)
29th Apr 20241:34 pmRNSNet Asset Value(s)
26th Apr 202412:06 pmRNSNet Asset Value(s)
25th Apr 20241:57 pmRNSNet Asset Value(s)
24th Apr 202412:34 pmRNSNet Asset Value(s)
23rd Apr 20241:00 pmRNSNet Asset Value(s)
22nd Apr 202412:54 pmRNSNet Asset Value(s)
19th Apr 20245:35 pmRNSTransaction in Own Shares
19th Apr 20243:39 pmRNSNet Asset Value(s)
19th Apr 20247:00 amRNSCompliance with Market Abuse Regulation
18th Apr 20245:40 pmRNSTransaction in Own Shares
18th Apr 202412:18 pmRNSNet Asset Value(s)
17th Apr 202412:24 pmRNSNet Asset Value(s)
16th Apr 202412:31 pmRNSNet Asset Value(s)
15th Apr 202412:44 pmRNSNet Asset Value(s)
12th Apr 20245:30 pmRNSTransaction in Own Shares
12th Apr 20242:09 pmRNSNet Asset Value(s)
11th Apr 20245:49 pmRNSTransaction in Own Shares
11th Apr 202412:59 pmRNSNet Asset Value(s)
10th Apr 20245:44 pmRNSTransaction in Own Shares
10th Apr 20241:01 pmRNSNet Asset Value(s)
9th Apr 20245:40 pmRNSTransaction in Own Shares
9th Apr 20243:48 pmRNSMonthly Factsheet
9th Apr 202412:20 pmRNSNet Asset Value(s)
9th Apr 202411:56 amRNSDirector/PDMR Shareholding
8th Apr 20244:58 pmRNSDirector/PDMR Shareholding
8th Apr 202412:58 pmRNSNet Asset Value(s)
8th Apr 202412:53 pmRNSAppointment of Corporate Broker
8th Apr 202412:39 pmRNSListing Rule 15.6.8
5th Apr 20241:57 pmRNSNet Asset Value(s)
4th Apr 20245:32 pmRNSTransaction in Own Shares
4th Apr 20241:13 pmRNSNet Asset Value(s)
3rd Apr 20245:32 pmRNSTransaction in Own Shares
3rd Apr 20242:28 pmRNSNet Asset Value(s)
3rd Apr 20247:00 amRNSKepler Trust Intelligence: New Research
2nd Apr 20245:30 pmRNSTransaction in Own Shares
2nd Apr 20244:32 pmRNSNet Asset Value(s)
2nd Apr 202412:31 pmRNSTotal Voting Rights
28th Mar 20245:32 pmRNSTransaction in Own Shares
28th Mar 20242:08 pmRNSNet Asset Value(s)
27th Mar 20245:48 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.